Newsroom

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Analytical Chemistry, AI

Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptional Cost Efficiency

November 10, 2026

Categories: Omics & Genetics, Biotechnology, Computing & Technology, Drug Discovery & Development

One Year After Launch, Plasmidsaurus RNA-Seq Challenges RT-qPCR as the Standard for Routine Gene Expression Analysis

November 10, 2026

Categories: Pharma, Corporate, Finance & Investor, biopharma

Sciensus Appoints James Tugendhat OBE as Chief Executive Officer

October 28, 2026

Categories: Bioprocessing, Biomanufacturing, Biotechnology

Takara Bio Europe Introduces GMP-Grade Cellartis® MSC EV Wonder™ to Support Clinical-Scale Extracellular Vesicle Production

October 28, 2026

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Corporate, Finance & Investor

Samplix Secures Backing to Accelerate Xdrop’s Commercial Expansion in Antibody Discovery

October 27, 2026

Categories: Biomanufacturing, Healthcare, Clinical Research & Trials, Medical Devices & Technology

Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI facility

October 22, 2026

Categories: Biotechnology, Diagnostics & Hospital Laboratory, Clinical Diagnostics

Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance

October 6, 2026

Categories: Diagnostics & Hospital Laboratory, Drug Discovery & Development, Clinical Research & Trials, Clinical Diagnostics, biopharma

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

October 5, 2026

Categories: Diagnostics & Hospital Laboratory, Clinical Research & Trials, biopharma, Digital Pathology, AI

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

October 1, 2026